Kraig Biocraft Laboratories Preparing Response To U.S. Department Of Defense Request For Information On Domestic Biomanufacturing Of Spider Silk

ANN ARBOR, Mich. — April 5, 2023 — Kraig Biocraft Laboratories Inc., the biotechnology company focused on the development and commercialization of spider silk, announces today that it is preparing a response to the United States Air Force under the Defense Production Act Investments (DPAI) program. In its efforts to strengthen the U.S. bio-industrial manufacturing capabilities, the U.S. Government is seeking input from industry to identify target areas for governmental investment.

Under the 2023 National Defense Authorization Act and through executive order, the Secretary of Defense has been authorized to “incentives the expansion of domestic, flexible industrial biomanufacturing capacity for a wide range of materials.” Biosynthetic fibers such as spider silk were specifically identified as a material/technology of interest under this directive.

Kraig Labs is preparing a detailed response for submission to the U.S. Air Force by its April 19 deadline. While this request for information does not guarantee a subsequent request for proposal or that funding will be available, it does signify the importance that materials, such as spider silk, can play both economically and defensively.

“We are very pleased to see the renewed support and interest from the Department of Defense (DoD) to strength the U.S. industry supply base for bio-engineering and bio-manufactured materials,” said company COO Jon Rice. “I believe that Kraig Labs is and will remain a key player in our domestic biomanufacturing capabilities, and we welcome the opportunity to bring the DoD up to date with our progress and the opportunities that lie ahead.”

Posted: April 5, 2023

Source: Kraig Biocraft Laboratories, Inc.